These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18308743)

  • 1. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.
    Uusküla A; Kals M; Rajaleid K; Abel K; Talu A; Rüütel K; Platt L; Rhodes T; Dehovitz J; Des Jarlais D
    J Public Health (Oxf); 2008 Jun; 30(2):119-25. PubMed ID: 18308743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia.
    Uusküla A; Des Jarlais DC; Kals M; Rüütel K; Abel-Ollo K; Talu A; Sobolev I
    BMC Public Health; 2011 Jun; 11():517. PubMed ID: 21718469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV prevalence and gender differences among new injection-drug-users in Tallinn, Estonia: A persisting problem in a stable high prevalence epidemic.
    Uusküla A; Raag M; Marsh K; Talu A; Vorobjov S; Des Jarlais D
    PLoS One; 2017; 12(2):e0170956. PubMed ID: 28152026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants--Is Prevention Failing?
    Folch C; Casabona J; Espelt A; Majó X; Meroño M; Gonzalez V; Wiessing L; Colom J; Brugal MT;
    Subst Use Misuse; 2016 Jan; 51(2):250-60. PubMed ID: 26820260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
    Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
    Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with HIV testing among male injecting drug users: findings from a cross-sectional behavioural and biological survey in Manipur and Nagaland, India.
    Ganju D; Ramesh S; Saggurti N
    Harm Reduct J; 2016 Jun; 13(1):21. PubMed ID: 27324253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk behavior and HIV infection among new drug injectors in the era of AIDS in New York City.
    Des Jarlais DC; Friedman SR; Perlis T; Chapman TF; Sotheran JL; Paone D; Monterroso E; Neaigus A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Jan; 20(1):67-72. PubMed ID: 9928732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An analysis of respondent-driven sampling with injecting drug users in a high HIV prevalent state of India.
    Phukan SK; Medhi GK; Mahanta J; Adhikary R; Thongamba G; Paranjape RS; Akoijam BS
    Harm Reduct J; 2017 Jul; 14(1):41. PubMed ID: 28673303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam.
    Des Jarlais DC; Thi Huong D; Thi Hai Oanh K; Khuê Pham M; Thi Giang H; Thi Tuyet Thanh N; Arasteh K; Feelemyer J; Hammett T; Peries M; Michel L; Vu Hai V; Roustide MJ; Moles JP; Laureillard D; Nagot N;
    Int J Drug Policy; 2016 Jun; 32():50-6. PubMed ID: 27006257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
    Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
    Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of markers for hepatitis B virus and HIV-1 among drug injectors in London: injecting careers, positivity and risk behaviour.
    Rhodes T; Hunter GM; Stimson GV; Donoghoe MC; Noble A; Parry J; Chalmers C
    Addiction; 1996 Oct; 91(10):1457-67. PubMed ID: 8917914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden.
    Tarján A; Dudás M; Wiessing L; Horváth G; Rusvai E; Tresó B; Csohán Á
    Int J Drug Policy; 2017 Mar; 41():1-7. PubMed ID: 27984762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socio-demographic factors, health risks and harms associated with early initiation of injection among people who inject drugs in Tallinn, Estonia: evidence from cross-sectional surveys.
    Vorobjov S; Des Jarlais DC; Abel-Ollo K; Talu A; Rüütel K; Uusküla A
    Int J Drug Policy; 2013 Mar; 24(2):150-5. PubMed ID: 23036651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Informed altruism" and "partner restriction" in the reduction of HIV infection in injecting drug users entering detoxification treatment in New York City, 1990-2001.
    Des Jarlais DC; Perlis T; Arasteh K; Hagan H; Milliken J; Braine N; Yancovitz S; Mildvan D; Perlman DC; Maslow C; Friedman SR
    J Acquir Immune Defic Syndr; 2004 Feb; 35(2):158-66. PubMed ID: 14722449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of injecting in an HIV incidence hotspot among substance users in Tijuana, Mexico.
    Kori N; Roth AM; Lozada R; Vera A; Brouwer KC
    Int J Drug Policy; 2014 May; 25(3):525-32. PubMed ID: 24418632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk behaviors for HIV transmission among the recent clients of a syringe-exchange program in Madrid, 1993].
    Bravo Portela MJ; Barrio Anta G; de la Fuente de Hoz L; Colomo Gómez C; Royuela Morales L; Estébanez Estébanez P
    Gac Sanit; 1996; 10(57):261-73. PubMed ID: 9072510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV and hepatitis C virus risk in new and longer-term injecting drug users in Oslo, Norway.
    Miller M; Mella I; Moi H; Eskild A
    J Acquir Immune Defic Syndr; 2003 Jul; 33(3):373-9. PubMed ID: 12843749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia.
    Uusküla A; McNutt LA; Dehovitz J; Fischer K; Heimer R
    Int J STD AIDS; 2007 Jan; 18(1):41-6. PubMed ID: 17326862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors.
    Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Torian LV; Beatice S; Semaan S; Friedman SR
    Drug Alcohol Depend; 2010 Jun; 109(1-3):154-60. PubMed ID: 20163922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.